Alkermes
potential new revenue driver in oral atypical market daily oral investigational designed to offer efficacy of for adults with schizophrenia and adults with bipolar i disorder addition of intended to mitigate associated weight gain date june anticipated launch alkermes value proposition drive operating leverage from established psychiatry commercial infrastructure expected to be accretive in year of launch the brand name has been conditionally accepted by the and will be confirmed upon approval resubmission under review following complete response letter and records requests relating to manufacturing of enlighten phase results higher mean percent weight change at six months for patients who received the risk of clinically meaningful weight gain from for for enlighten double blind randomized phase study that evaluated the weight gain profile of compared to over six months in patients with stable schizophrenia most common adverse events for weight gain somnolence dry mouth most common adverse events for weight gain somnolence increased appetite launch planning target well defined provider call universe at launch implement patient access programs designed to mitigate payer restrictions early in launch | Alkermes
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
20 of 144
Related slides by other companies
AstraZeneca
Results
February 2024
investing in new launches near and mid term pipeline phase trials initiated across medicines phase trials initiated with blockbuster potential regulatory approvals in major markets new medicines approved and on track to deliver on ambition for at least launches by | AstraZeneca
Faraday Future
Investor Presentation
October 2022
after sales service predictive service user scheduling in service network network mobile | Faraday Future
Other recent decks by Alkermes
See all presentations (22 decks)
Investor Conference
January 2024
Results
October 2023
Investor Presentation
October 2023
Results
July 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io